Axsome Therapeutics, Inc. (AXSM)

Seite 1 von 1
neuester Beitrag:  30.10.17 10:16
eröffnet am: 30.10.17 10:15 von: Chalifmann3 Anzahl Beiträge: 2
neuester Beitrag: 30.10.17 10:16 von: Chalifmann3 Leser gesamt: 825
davon Heute: 1
bewertet mit 0 Sternen

30.10.17 10:15 #1 Axsome Therapeutics, Inc. (AXSM)
Top Chance auf Blockbuster ,hm ??!!  
30.10.17 10:16 #2 hier

Axsome Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the management of central nervous system (CNS) disorders. The company’s product candidates include AXS-05 that is in Phase III trial for the treatment of treatment resistant depression and Alzheimer’s disease agitation; and AXS-02, which is in Phase III trial to treat complex regional pain syndrome, knee osteoarthritis related to bone marrow lesions, and chronic low back pain related to Modic changes. It is also developing AXS-06, a preclinical product candidate for CNS disorders, including chronic pain. The company was founded in 2012 and is based in New York, New York.

Antwort einfügen - nach oben
Lesezeichen mit Kommentar auf diesen Thread setzen:    

Bitte warten...